​

Mural Oncology Ownership | Who Owns Mural Oncology?

OverviewRevenueFinancialsChart

Mural Oncology Ownership Summary

Mural Oncology is owned by 47.68% institutional investors, 13.03% insiders, and 39.29% retail investors. Soleus capital management is the largest institutional shareholder, holding 7.66% of MURA shares.

MURA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMural Oncology47.68%13.03%39.29%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Soleus capital management1.32M7.66%$3.27M
Prosight management, lp900.00K5.21%$2.22M
Orbimed advisors588.80K3.41%$1.45M
Newtyn management570.00K3.30%$1.41M
Lmr partners llp516.42K2.99%$1.28M
Diametric capital, lp350.00K2.03%$864.50K
Blackrock funding, inc. /de286.40K1.66%$707.41K
Rbf capital283.91K1.64%$701.26K
Millennium management169.00K1.00%$212.94K
Verition fund management157.50K0.91%$389.02K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Prosight management, lp900.00K0.54%$2.22M
Diametric capital, lp350.00K0.46%$864.50K
Soleus capital management1.32M0.22%$3.27M
Newtyn management570.00K0.21%$1.41M
Hgc investment management87.97K0.06%$217.28K
Orbimed advisors588.80K0.04%$1.45M
Rbf capital283.91K0.03%$701.26K
Prelude capital management136.93K0.03%$338.23K
Fifth lane capital, lp10.00K0.03%$24.70K
Emerald mutual fund advisers trust77.57K0.01%$191.59K

Top Buyers

HolderShares% AssetsChange
Soleus capital management1.32M0.22%1.32M
Orbimed advisors588.80K0.04%588.80K
Lmr partners llp516.42K0.01%516.42K
Prosight management, lp900.00K0.54%477.26K
Diametric capital, lp350.00K0.46%350.00K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.72M
Solas capital management---888.00K
Squarepoint ops---175.50K
Bridgeway capital management---115.87K
Shay capital---113.52K

New Positions

HolderShares% AssetsChangeValue
Soleus capital management1.32M0.22%1.32M$3.27M
Orbimed advisors588.80K0.04%588.80K$1.45M
Lmr partners llp516.42K0.01%516.42K$1.28M
Diametric capital, lp350.00K0.46%350.00K$864.50K
Prelude capital management136.93K0.03%136.93K$338.23K

Sold Out

HolderChange
Versant capital management-1.00
Bell investment advisors-4.00
Cranbrook wealth management-4.00
Ronald blue trust-6.00
Northwestern mutual wealth management-10.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202566-1.49%8,234,676-1.91%471.99%2728.57%20-20.00%
Mar 31, 20254-94.59%2,749,454-70.69%160.54%1-96.15%3-86.96%
Dec 31, 2024745.71%9,381,197-1.48%541.76%2618.18%23-11.54%
Sep 30, 202470-14.63%9,521,654-12.63%551.35%22-31.25%26-16.13%
Jun 30, 202482-14.58%10,897,815-9.88%641.24%326.67%31-34.04%

Recent Insider Transactions

DateNameRoleActivityValue
Jul 22, 2025Keson-Brookes Maiken See RemarksSell$6.38K
Jul 18, 2025Keson-Brookes Maiken See RemarksSell$5.35K
Jul 07, 2025Loew Caroline Chief Executive OfficerSell$30.48K
Mar 04, 2025Keson-Brookes Maiken See RemarksSell$4.24K
Mar 05, 2025Keson-Brookes Maiken See RemarksSell$5.07K

Insider Transactions Trends

DateBuySell
2025 Q3-3
2025 Q2--
2025 Q1-4
2024 Q4-4
2024 Q312

MURA Ownership FAQ

Who Owns Mural Oncology?

Mural Oncology shareholders are primarily institutional investors at 47.68%, followed by 13.03% insiders and 39.29% retail investors. The average institutional ownership in Mural Oncology's industry, Biotech Stocks , is 306.59%, which Mural Oncology falls below.

Who owns the most shares of Mural Oncology?

Mural Oncology’s largest shareholders are Soleus capital management (1.32M shares, 7.66%), Prosight management, lp (900K shares, 5.21%), and Orbimed advisors (588.8K shares, 3.41%). Together, they hold 16.28% of Mural Oncology’s total shares outstanding.

Does Blackrock own Mural Oncology?

BlackRock is not among the top 10 institutional shareholders of Mural Oncology.

Who is Mural Oncology’s biggest shareholder by percentage of total assets invested?

Prosight management, lp is Mural Oncology’s biggest shareholder by percentage of total assets invested, with 0.54% of its assets in 900K Mural Oncology shares, valued at 2.22M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools